Member Info for beinthelead

We’re not as popular these days so good time to get back.

Great mate. Hope you’re well - you back??

It’s quiet because there’s nothing left to say.

The thread should be deleted. It’s self indulgent at best.

The market is now secondary. Fix it, get it back on the market. Any rev’s will help.

The real prize is superseding the Mab with an Affimer. This is only thing left exciting me with the LFT.

Charts are not valid. They only verify hindsight.

Kevin - totally agree with your message by the way. This has so many parallels with the LFT. I was convinced we’d sell all we make. Not sure why? Anyway, things can unravel quickly.

Also P3 trials wasn’t it? Their trial design was controversial and any P3 has some back end loaded risk. In theory, this P1a is less varied and has a more scaleable outcome.

Cheers Tom - saw that one. Does beggars belief. Looking forward to an exciting couple of months.

Is it AS’s rampy past that is blocking the SP’s progression? I’ve not a great deal of experience in SP’s that explode from day to the next. Does it really happen where we are bought out for £50 in the next 12 months? Mind boggling.

All research points to success.

Thanks Timster. I only conclude the same thing - with every scenario dominating my thoughts of late.

Exactly this. Been head scratching the last couple of weeks. Can it really happen???

https://twitter.com/Cumulus51896691/status/1516146797412036615?s=20&t=3oigzNdZ2DRc4Rbwx__B6Q

Social media wins elections. Look it up, it’s quite influential.

If it was overvalued then, it’s overvalued now?

Fair shout :)

Wyn - we have no rampers left on the board. Maybe Tom - no offence meant.

Can you explain why we had a deluge of trolls from 160p all the at down to 40p? They’re no longer here.

The LFT made us (un)popular. We’re no where we are. Thankful that the trolls are gone.

Truant/Ndn/Bishop - they’re all the same avatar. All obsessed with Avacta. All running shorts since 60p? Leave them to it.

Isn’t it funny how the trolls have gone? Somebody pointed to a Brontë closure the other day. My guess is that they were/are employed by them. Looking at their investment strategy leaves that conclusion more obvious than ever.

We’re weeks away from a proposed DE, which should infer and improved chance of success. RAH is rampy - but he provides a very well reasoned side of their argument.

Let it run over the next few weeks. We’ll have our answer soon.

From previous reading; if the patented drug metabolites are ‘exposed’ at some point in the chemical process, they are subject to the patent.

There may be a case to extend the patent in pro-drug form? Ergo, Velcade.

Yes. That’s why they’re using an analogue during development.

I think it’s simpler. They’ve created an analogue of velcade to avoid IP breach.